FDA Approves First Drug Treatment of Chronic Movement Disorder

Huntington’s disease (HD) is a genetic neurological disorder characterized by abnormal body movements called chorea and a lack of coordination; it also affects a number of mental abilities and some aspects of behavior. In more advanced stages it can cause complications that significantly reduce life expectancy.

The disorder is named after George Huntington, the American physician who first described it in 1872. Just over 120 years later, the altered gene that causes HD was discovered, making it one of the first inherited genetic disorders for which an accurate test could be performed. Because of this, and because of the characteristics the disorder shares with some other neurological disorders, it has been extensively researched since then.

Now, you can count a drug for HD among the priorities of researchers. | LINK